Navigation Links
Jazz Pharmaceuticals, Inc. Announces Board of Directors and Management Changes
Date:4/2/2009

PALO ALTO, Calif., April 2 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that Samuel R. Saks, its Chief Executive Officer and a member of its Board of Directors, has resigned from both positions, effective as of April 3, 2009. Dr. Saks will serve as a consultant to the company on medical and clinical matters after his departure.

"We thank Sam for his enormous contributions to Jazz Pharmaceuticals since its founding in 2003," said Bruce C. Cozadd, the company's Executive Chairman. "His dedication to patients, employees and our company culture has been an inspiration to all of us," he continued.

The Board of Directors has appointed Bruce C. Cozadd as the company's Chief Executive Officer. Mr. Cozadd has been Jazz Pharmaceuticals' Executive Chairman, and a member of the Board of Directors, since the company's founding in 2003. From 1991 until 2001, he held various positions with ALZA Corporation, a pharmaceutical company now owned by Johnson & Johnson, most recently as its Executive Vice President and Chief Operating Officer, with responsibility for research and development, manufacturing and sales and marketing. Previously at ALZA Corporation, he held the roles of Chief Financial Officer and Vice President, Corporate Planning and Analysis. Mr. Cozadd received a B.S. from Yale University and an M.B.A. from the Stanford Graduate School of Business. Mr. Cozadd serves on the boards of Cerus Corporation, a biopharmaceutical company; Threshold Pharmaceuticals, a biotechnology company; and The Nueva School and Stanford Hospital and Clinics, both non-profit organizations.

The Board of Directors has appointed Robert M. Myers, Jazz Pharmaceuticals' President, to the Board of Directors to fill the vacancy on the Board of Directors created by Dr. Saks' resignation. Mr. Mye
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
7. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
8. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
9. Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
10. Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
11. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2014)... Parker & Sons, Inc. a focused and ... in contractor services announces reaching a milestone by providing ... of Arizona. Parker and Sons is comprised of a ... make customer service the number one priority. The company ... with one service vehicle and has since grown to ...
(Date:12/19/2014)... Today, Balfleet.com , a leading ... its formal dress promotion. All the old and new ... off. , Balfleet.com is well-known for its high quality ... dresses, cocktail dresses and more. Its formal dresses are ... and they can create an elegant look when paired ...
(Date:12/19/2014)... 20, 2014 Sweetdressy.com , a ... introduced its newest selection of cheap prom dresses for ... popular in the world and clients can buy these ... these prom dresses feature cool cuts and delicate craftsmanship, ... targeting the middle-end market. Discount shipping costs are available ...
(Date:12/19/2014)... FL (PRWEB) December 19, 2014 ... Revitalizing Bedsheets are now available. Celliant, the world’s ... both sheets and pillowcases. , There are a ... proven additional circulation, increased oxygenation and balanced body ... faster healing and pain relief; enhanced athletic performance; ...
(Date:12/19/2014)... Branson, Missouri (PRWEB) December 19, 2014 ... a new official world record -- for the first time ... most prestigious record book, Guinness World Records 2015, listing the ... Steepest Wooden Roller Coaster. In additional awards announced this week, ... to See Christmas Lights in the US,” USA Today’s 10Best ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 3Health News:Balfleet.com Announces Its Formal Dress Promotion For 2015 2Health News:Cheap Prom Dresses Online Now at Sweetdressy.com 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2
... , WEDNESDAY, Aug. 18 (HealthDay News) -- Although it,s long ... produce any insulin after they,ve had the disease for a ... by type 1 diabetes may actually be in a constant ... decades. , This new research stems from a study ...
... for more than 1,800 years reduced the gastrointestinal side ... effects of the cancer treatment, Yale University researchers report. ... four herbs, called PHY906, and is based on a ... treat nausea, vomiting and diarrhea. The study, published August ...
... Goodwin HealthDay Reporter , WEDNESDAY, Aug. 18 (HealthDay ... cigarettes have emerged as one of the most controversial products ... to them, with nearly 45 percent of smokers aged 12 ... Survey on Drug Use and Health. Most black teenaged smokers ...
... (CHICAGO) Neurological and infectious disease experts at Rush University ... treatment of individuals with West Nile fever or suspected central ... Rush is the only site in the Midwest enrolling patients ... called PARADIGM. The new drug treatment for West ...
... health and science communications firm, announced the results of ... children identified with a rare, fatal, and rapid aging ... a Centers for Disease Control national conference on health ... living in 30 countries had been identified with Progeria, ...
... Middle-aged and elderly Swedish women who regularly ate a small ... in a study reported in Circulation: Heart Failure , ... conducted among 31,823 middle-aged and elderly Swedish women, looked at ... ate, compared to their risk for heart failure. The quality ...
Cached Medicine News:Health News:Long-Term Type 1 Diabetes 'Survivors' Give Clues to the Disease 2Health News:Long-Term Type 1 Diabetes 'Survivors' Give Clues to the Disease 3Health News:FDA Mulling Ban on Menthol Cigarettes 2Health News:FDA Mulling Ban on Menthol Cigarettes 3Health News:FDA Mulling Ban on Menthol Cigarettes 4Health News:Study to examine new treatment for West Nile virus 2Health News:Global media campaign finds 'hidden' children with rare, fatal aging disorder 2Health News:Moderate chocolate consumption linked to lower risks of heart failure 2Health News:Moderate chocolate consumption linked to lower risks of heart failure 3
(Date:12/17/2014)... SAN DIEGO , Dec. 17, 2014 /PRNewswire/ ... AEX: PHIA) and Volcano Corporation (NASDAQ: VOLC ), ... cardiovascular applications, today announced that they have entered into a ... a tender offer to acquire all of the issued and ... a total equity purchase price of USD 1 billion (approx. ...
(Date:12/17/2014)... With advancements in neurological and functional ... seeing new growth, according to Kalorama Information. Though ... the majority of market volume, newer 3T systems ... are creating opportunities for more sophisticated applications. The medical ... a rate of 4%, with world market revenues ...
(Date:12/17/2014)... 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... developing and commercializing innovative therapies addressing major unmet ... enrollment in its first Phase 2a study, RXI-109-1301.  ... the 1-month findings that were reported in September ... http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , , , ...
Breaking Medicine Technology:Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... MOST Options System is designed to ... of the knee or hip to ... provides the potential for restoration of ... the requirements of a rotating hinge ...
... System (OSS) from Biomet Inc. offers ... designed specifically for orthopaedic surgeons and ... in their patients: significant bone loss, ... revision arthroplasties, and multiple hip revision ...
... Surgical Helmet System from DePuy offers a ... system helps meet OSHA recommendations regarding occupational ... creating a new standard for comfort. ... offer unequaled comfort, featuring a lightweight, hose-free, ...
DePuy's Shoe Boots are sealed thermoplastic boots that help provide splash protection from microorganisms, particulate matter and body fluids....
Medicine Products: